November 25, 2019 / 5:43 PM / 15 days ago

Sanofi ex-employee can join hemophilia treatment rival BioMarin - judge

Sanofi SA’s Genzyme unit cannot block a former employee from joining BioMarin Pharmaceutical Inc, where he would help launch a gene therapy treatment for hemophilia that would compete with a drug his ex-employer markets, a Massachusetts judge has ruled.

Suffolk County Superior Court Judge Janet Sanders in Boston on Friday ruled Genzyme had failed to show why a preliminary injunction enforcing a non-compete agreement Keith Hanglin signed was needed to protect any of its legitimate business interests.

To read the full story on WestlawNext Practitioner Insights, click here: bit.ly/2OjWuAR

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below